Search

Author/Creator Lordick, F

1. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Lordick, F; Tsushima, T; Pentheroudakis, G; Baba, E; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Kato, K; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Nakajima, T E; Shitara, K; Kawakami, H; Narita, Y
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Van Cutsem, E; Narita, Y; Pentheroudakis, G; Baba, E; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Kato, K; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Nakajima, T E; Shitara, K; Kawakami, H; Tsushima, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. (23rd August 2018)

Authors:
Dietz, A; Wichmann, G; Kuhnt, T; Pfreundner, L; Hagen, R; Scheich, M; Kölbl, O; Hautmann, M G; Strutz, J; Schreiber, F; Bockmühl, U; Schilling, V; Feyer, P; de Wit, M; Maschmeyer, G; Jungehülsing, M; Schroeder, U; Wollenberg, B; Sittel, C; Münter, M
Journal:
Annals of oncology
Issue:
Volume 29:Number 10(2018)
Page Start:
2105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 198TiPSPOTLIGHT: Comparison of zolbetuximab or placebo + mFOLFOX6 as first-line treatment in patients with claudin18.2+/HER2– locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (GEJ): A randomized phase III study. (24th November 2019)

Authors:
Yamaguchi, K; Shitara, K; Al-Batran, S-E; Bang, Y-J; Catenacci, D; Enzinger, P; Ilson, D; Kim, S; Lordick, F; Shah, M; Van Cutsem, E; Xu, R-H; Arozullah, A; Wook Park, J; Ajani, J
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 197TiPGLOW: Zolbetuximab + CAPOX compared with placebo + CAPOX as first-line treatment for patients with Claudin18.2+/HER2– Locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: A randomized phase III study. (24th November 2019)

Authors:
Xu, R-H; Dongsheng, Z; Ajani, J; Al-Batran, S-E; Bang, Y-J; Catenacci, D; Enzinger, P; Ilson, D; Kim, S; Lordick, F; Shitara, K; Van Cutsem, E; Arozullah, A; Wook Park, J; Shah, M
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases. (20th February 2014)

Authors:
Homayounfar, K; Bleckmann, A; Helms, H-J; Lordick, F; Rüschoff, J; Conradi, L-C; Sprenger, T; Ghadimi, M; Liersch, T
Journal:
British journal of surgery
Issue:
Volume 101(2014)Supplement 5
Page Start:
550
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗